Skip to main content
Erschienen in: Pediatric Cardiology 3/2018

14.12.2017 | Original Article

Exercise Performance in Pediatric Liver Transplant Recipients and Its Related Cardiac Function

verfasst von: Seyed Mohsen Dehghani, Mitra Moshref, Hamid Amoozgar, Seyed Ali Malek Hoseini, Saman Nikeghbalian

Erschienen in: Pediatric Cardiology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate an exercise test in pediatric liver transplant recipients and its relation to their cardiac function. This cross-sectional study was conducted on 58 children who had successfully undergone orthotopic liver transplantation at least 6 months prior to the study, with the same age and gender-matched control group. M-mode, Doppler, tissue Doppler echocardiography and an exercise test were performed for all the participants. The VO2 values and METS in patients were less than the control (P = 0.001). Left ventricular posterior wall thickness in systole, left ventricular posterior wall thickness in diastole, interventricular septum diameter in diastole, AT, pulmonary acceleration time, ST and EaT, AaM, and SS had a significant difference between patients and the control group (P value < 0.05). Maximal oxygen consumption (Max VO2) and metabolic equivalent task (METs) values had a significant correlation with tricuspid valve S parameter (P = 0.018, r = 0.310). Max VO2 and METs values did not have a significant correlation with the diastolic dysfunction index, such as E/A and E/Ea. In this study, the exercise test showed decreased functional capacity in liver-transplanted children; however, the echocardiographic evaluation did not reveal any definite correlation with systolic or diastolic dysfunction.
Literatur
1.
Zurück zum Zitat McDiarmid SV (2001) Management of the pediatric liver transplant patient. Liver Transpl 7(1):S77–S86CrossRefPubMed McDiarmid SV (2001) Management of the pediatric liver transplant patient. Liver Transpl 7(1):S77–S86CrossRefPubMed
2.
Zurück zum Zitat Englesbe MJ, Kelly B, Goss J, Fecteau A, Mitchell J, Andrews W et al (2012) Reducing pediatric liver transplant complications: a potential roadmap for transplant quality improvement initiatives within North America. Am J Transpl 12(9):2301–2306CrossRef Englesbe MJ, Kelly B, Goss J, Fecteau A, Mitchell J, Andrews W et al (2012) Reducing pediatric liver transplant complications: a potential roadmap for transplant quality improvement initiatives within North America. Am J Transpl 12(9):2301–2306CrossRef
3.
Zurück zum Zitat Neviere R, Edme JL, Montaigne D, Boleslawski E, Pruvot FR, Dharancy S (2014) Prognostic implications of preoperative aerobic capacity and exercise oscillatory ventilation after liver transplantation. Am J Transpl 14(1):88–95CrossRef Neviere R, Edme JL, Montaigne D, Boleslawski E, Pruvot FR, Dharancy S (2014) Prognostic implications of preoperative aerobic capacity and exercise oscillatory ventilation after liver transplantation. Am J Transpl 14(1):88–95CrossRef
4.
Zurück zum Zitat Zaky A, Bendjelid K (2015) Appraising cardiac dysfunction in liver transplantation: an ongoing challenge. Liver Int 35(1):12–29CrossRefPubMed Zaky A, Bendjelid K (2015) Appraising cardiac dysfunction in liver transplantation: an ongoing challenge. Liver Int 35(1):12–29CrossRefPubMed
5.
Zurück zum Zitat Khemakanok K, Khositseth A, Treepongkaruna S, Teeraratkul S, Pansrimangkorn W, Leelaudomlipi S et al (2015) Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation. Hepatol Int 10(3):518–524CrossRefPubMed Khemakanok K, Khositseth A, Treepongkaruna S, Teeraratkul S, Pansrimangkorn W, Leelaudomlipi S et al (2015) Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation. Hepatol Int 10(3):518–524CrossRefPubMed
6.
Zurück zum Zitat Graham RM (1994) Cyclosporine: mechanisms of action and toxicity. Cleve Clin J Med. 61(4):308–313CrossRefPubMed Graham RM (1994) Cyclosporine: mechanisms of action and toxicity. Cleve Clin J Med. 61(4):308–313CrossRefPubMed
7.
Zurück zum Zitat Ventura HO, Malik FS, Mehra MR, Stapleton DD, Smart FW (1997) Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol 12(4):375–381PubMed Ventura HO, Malik FS, Mehra MR, Stapleton DD, Smart FW (1997) Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol 12(4):375–381PubMed
8.
Zurück zum Zitat Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, and et al (2000) Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 70(4):617–625CrossRefPubMedPubMedCentral Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, and et al (2000) Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 70(4):617–625CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Mandell MS, Lindenfeld J, Tsou MY, Zimmerman M (2008) Cardiac evaluation of liver transplant candidates. World J Gastroenterol 14(22):3445–3451CrossRefPubMedPubMedCentral Mandell MS, Lindenfeld J, Tsou MY, Zimmerman M (2008) Cardiac evaluation of liver transplant candidates. World J Gastroenterol 14(22):3445–3451CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Raval Z, Harinstein ME, Skaro AI, Erdogan A, DeWolf AM, Shah SJ et al (2011) Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol 58(3):223–231CrossRefPubMed Raval Z, Harinstein ME, Skaro AI, Erdogan A, DeWolf AM, Shah SJ et al (2011) Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol 58(3):223–231CrossRefPubMed
11.
Zurück zum Zitat Maria da Silva R, Brunow de Carvalho W, Johnston C, Borba de Castro M, Manta Ferreira I, Patti CL et al (2014) Functional capacity after pediatric liver transplantation: a pilot study. Pediatr Transpl 18(6):586–593CrossRef Maria da Silva R, Brunow de Carvalho W, Johnston C, Borba de Castro M, Manta Ferreira I, Patti CL et al (2014) Functional capacity after pediatric liver transplantation: a pilot study. Pediatr Transpl 18(6):586–593CrossRef
12.
Zurück zum Zitat Derakhshan A, Derakhshan D, Amoozgar H, Shakiba MA, Basiratnia M, Fallahzadeh MH (2014) Exercise test in pediatric renal transplant recipients and its relationship with their cardiac function. Pediatr Transpl 18(3):246–253CrossRef Derakhshan A, Derakhshan D, Amoozgar H, Shakiba MA, Basiratnia M, Fallahzadeh MH (2014) Exercise test in pediatric renal transplant recipients and its relationship with their cardiac function. Pediatr Transpl 18(3):246–253CrossRef
13.
Zurück zum Zitat Abd-El-Aziz TA, Abdou M, Fathy A, Wafaie M (2010) Evaluation of cardiac function in patients with liver cirrhosis. Intern Med 49(23):2547–2552CrossRefPubMed Abd-El-Aziz TA, Abdou M, Fathy A, Wafaie M (2010) Evaluation of cardiac function in patients with liver cirrhosis. Intern Med 49(23):2547–2552CrossRefPubMed
14.
Zurück zum Zitat Chen Y, Chan AC, Chan SC, Chok SH, Sharr W, Fung J et al (2016) A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation. J Cardiol 67(2):140–146CrossRefPubMed Chen Y, Chan AC, Chan SC, Chok SH, Sharr W, Fung J et al (2016) A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation. J Cardiol 67(2):140–146CrossRefPubMed
15.
Zurück zum Zitat Shalev A, Nir A, Granot E (2005) Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage. Pediatr Transpl 9(6):718–722CrossRef Shalev A, Nir A, Granot E (2005) Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage. Pediatr Transpl 9(6):718–722CrossRef
16.
Zurück zum Zitat Vandekerckhove K, Coomans I, De Bruyne E, De Groote K, Panzer J, De Wolf D, Boone J, De Bruyne R (2016) Evaluation of exercise performance, cardiac function, and quality of life in children after liver transplantation. Transplantation 100(7):1525–1531CrossRefPubMed Vandekerckhove K, Coomans I, De Bruyne E, De Groote K, Panzer J, De Wolf D, Boone J, De Bruyne R (2016) Evaluation of exercise performance, cardiac function, and quality of life in children after liver transplantation. Transplantation 100(7):1525–1531CrossRefPubMed
17.
Zurück zum Zitat Rongies W, Stepniewska S, Lewandowska M, Smolis-Bak E, Dolecki W, Sierdzinski J, Trzepla E, Cholewinska G, Stankiewicz W (2011) Physical activity long-term after liver transplantation yields better quality of life. Ann Transplant 16(3):126–131CrossRefPubMed Rongies W, Stepniewska S, Lewandowska M, Smolis-Bak E, Dolecki W, Sierdzinski J, Trzepla E, Cholewinska G, Stankiewicz W (2011) Physical activity long-term after liver transplantation yields better quality of life. Ann Transplant 16(3):126–131CrossRefPubMed
18.
Zurück zum Zitat Beyer N, Aadahl M, Strange B, Kirkegaard P, Hansen BA, Mohr T, Kjaer M (1999) Improved physical performance after orthotopic liver transplantation. Liver Transpl Surg 5(4):301–309CrossRefPubMed Beyer N, Aadahl M, Strange B, Kirkegaard P, Hansen BA, Mohr T, Kjaer M (1999) Improved physical performance after orthotopic liver transplantation. Liver Transpl Surg 5(4):301–309CrossRefPubMed
19.
Zurück zum Zitat Lemyze M, Dharancy S, Nevière R, Pruvot FR, Declerck N, Wallaert B (2010) Aerobic capacity in patients with chronic liver disease: very modest effect of liver transplantation. Presse Med 39(7–8):e174–e181CrossRefPubMed Lemyze M, Dharancy S, Nevière R, Pruvot FR, Declerck N, Wallaert B (2010) Aerobic capacity in patients with chronic liver disease: very modest effect of liver transplantation. Presse Med 39(7–8):e174–e181CrossRefPubMed
20.
Zurück zum Zitat Kotarska K, Wunsch E, Jodko L, Raszeja-Wyszomirska J, Bania I, Lawniczak M et al (2016) Factors affecting exercise test performance in patients after liver transplantation. Hepat Mon 16(3):e34356CrossRefPubMedPubMedCentral Kotarska K, Wunsch E, Jodko L, Raszeja-Wyszomirska J, Bania I, Lawniczak M et al (2016) Factors affecting exercise test performance in patients after liver transplantation. Hepat Mon 16(3):e34356CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Zaky A, Lang JD (2014) Cardiac Dysfunction in liver transplantation. Austin J Anesth Analg 2(1):1007 Zaky A, Lang JD (2014) Cardiac Dysfunction in liver transplantation. Austin J Anesth Analg 2(1):1007
Metadaten
Titel
Exercise Performance in Pediatric Liver Transplant Recipients and Its Related Cardiac Function
verfasst von
Seyed Mohsen Dehghani
Mitra Moshref
Hamid Amoozgar
Seyed Ali Malek Hoseini
Saman Nikeghbalian
Publikationsdatum
14.12.2017
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 3/2018
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-017-1786-3

Weitere Artikel der Ausgabe 3/2018

Pediatric Cardiology 3/2018 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.